Alyeska Investment Group
INBS icon

Alyeska Investment Group’s Intelligent Bio Solutions INBS Stock Holding History

Alyeska Investment Group’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,291
Closed -$428K – 610
2024
Q2 		$428K Hold
22,291
– – ﹤0.01% 509
2024
Q1 		$941K Buy
+22,291
New +$923K 0.01% 415

Other funds holding INBS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $293M AUM 14.23% 1-Year Est. Return

Alyeska Investment Group's INBS Position: Q1 2026 in Review

Alyeska Investment Group opened a new position in Intelligent Bio Solutions (INBS) in Q1 2026: 37,956 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #601 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in INBS as recently as Q3 2025.

Alyeska Investment Group first reported a position in INBS in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.06M in Q2 2025. 9 funds tracked by Wall St. Rank hold INBS as of Q1 2026.

  • Alyeska Investment Group held 37,956 shares of Intelligent Bio Solutions worth $127K as of Q1 2026.
  • Intelligent Bio Solutions was a new Alyeska Investment Group position in Q1 2026.
  • Intelligent Bio Solutions made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #601 holding.
  • Alyeska Investment Group first reported a position in Intelligent Bio Solutions in Q1 2024 and has held it in 6 quarters since.
  • Alyeska Investment Group's Intelligent Bio Solutions position peaked at $1.06M in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.